What is the most recent FDA action on file for MICRO LABS?

June 30, 2026. Argus HQ ingests new FDA enforcement records daily.

Is this FDA enforcement data for MICRO LABS official?

Every record links directly to its primary FDA.gov source. Argus HQ aggregates and structures public FDA data; the verbatim FDA record is always the source of truth.

What is the most recent FDA action against MICRO LABS?

The most recent FDA event Argus HQ has on file for MICRO LABS is dated 2026-06-30, with a severity rating of "info" in Argus HQ's classification. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

FDA Actions Against MICRO LABS | Argus HQ

Here's the summary: Argus HQ has recorded 4 FDA events for MICRO LABS: 0 warning letters, 0 recalls, 4 approvals, and 0 inspection 483 observations. These events span from 2026-06-23 to 2026-06-30. The most severe rating Argus HQ has assigned across this history is "info". Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

FDA action counts

Total FDA actions	4
Warning letters	0
Recalls	0
Approval records	4
Form 483 inspection citations	0
Most recent action	June 30, 2026

Enforcement history

On 2026-06-23, Argus HQ recorded a FDA approval for MICRO LABS, rated "info" severity in Argus HQ's classification: MICRO LABS — ANDA approval: FLUVOXAMINE MALEATE (unspecified) An FDA approval record reflects FDA clearing a specific drug or biologic application for marketing. On 2026-06-24, Argus HQ recorded a FDA approval for MICRO LABS, rated "info" severity in Argus HQ's classification: MICRO LABS — ANDA approval: PROPRANOLOL HYDROCHLORIDE (unspecified) An FDA approval record reflects FDA clearing a specific drug or biologic application for marketing. On 2026-06-29, Argus HQ recorded a FDA approval for MICRO LABS, rated "info" severity in Argus HQ's classification: MICRO LABS — ANDA approval: PRUCALOPRIDE SUCCINATE (unspecified) An FDA approval record reflects FDA clearing a specific drug or biologic application for marketing. On 2026-06-30, Argus HQ recorded a FDA approval for MICRO LABS, rated "info" severity in Argus HQ's classification: MICRO LABS — ANDA approval: RIVAROXABAN (unspecified) An FDA approval record reflects FDA clearing a specific drug or biologic application for marketing. In total, MICRO LABS has 4 FDA events on file with Argus HQ across the sources Argus HQ currently tracks (FDA Warning Letters, recalls, drug/biologic approvals, and Form 483 inspection observations). Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

Risk pattern analysis

Argus HQ analysis — not an FDA finding

This section is Argus HQ analysis, not an FDA finding. With 4 FDA events on file, there is not yet enough history in Argus HQ's database to describe a multi-event pattern beyond the single category involved. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

Frequently asked questions

What is the most recent FDA action on file for MICRO LABS?: June 30, 2026. Argus HQ ingests new FDA enforcement records daily.
Is this FDA enforcement data for MICRO LABS official?: Every record links directly to its primary FDA.gov source. Argus HQ aggregates and structures public FDA data; the verbatim FDA record is always the source of truth.
How many FDA actions has MICRO LABS had?: Argus HQ has recorded 4 FDA events for MICRO LABS: 0 warning letters, 0 recalls, 4 approvals, and 0 Form 483 inspection observations. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
What is the most recent FDA action against MICRO LABS?: The most recent FDA event Argus HQ has on file for MICRO LABS is dated 2026-06-30, with a severity rating of "info" in Argus HQ's classification. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Every FDA action tied to this company, the week it happens.

Free weekly briefing. Real-time alerts on paid plans.

Compare with

Two different companies merged onto this page by mistake? Or a name variant missing? Tell us — corrections@argushq.ai

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA

Argus HQ Research (2026). FDA Actions Against MICRO LABS. Digital Empire LLC. Retrieved from https://argushq.ai/company/micro-labs

MLA

"FDA Actions Against MICRO LABS." Argus HQ Research, Digital Empire LLC, 2026, argushq.ai/company/micro-labs.

Chicago

Argus HQ Research. "FDA Actions Against MICRO LABS." Digital Empire LLC. Accessed July 13, 2026. https://argushq.ai/company/micro-labs.

BibTeX

@misc{argushq_argushq_ai_company_micro_labs_2026,
  title = {FDA Actions Against MICRO LABS},
  author = {{Argus HQ Research}},
  year = {2026},
  publisher = {Digital Empire LLC},
  url = {https://argushq.ai/company/micro-labs},
  note = {Accessed: July 13, 2026}
}

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗